In present study, we examined EEG phenotypes, such as basal EEG power and ASSR, in Fmr1-KO rats and conducted a brief behavioral assessment to examine its utility as an alternative preclinical model for drug development in FXS. This evidence concerns the gene FMR1 and fragile X syndrome.